Crossmark

Thirteen years to get from b to a: one of the neglected isoforms of IL-37 enters the stage

Published Online: 2023-12-18

Authors

Cho, Steven X.

Rudloff, Ina https://orcid.org/0000-0002-7885-110X
Ellisdon, Andrew M.

Nold-Petry, Claudia A.

Nold, Marcel F. https://orcid.org/0000-0001-9682-4618
License Information

Text and Data Mining valid from 2023-12-18

Version of Record valid from 2023-12-18
More Information

Article History

Received: 14 November 2023

Accepted: 15 November 2023

First Online: 18 December 2023

Change Date: 21 March 2025

Change Type: Update

Change Details: Bi-directional link was added.

Competing interests

: AME, CANP, and MFN hold patents on the therapeutic use of IL-37.

Document is current